CLINICAL_TRIALS
trial_result
· 2009-06-23
Clinical Trial Update: BAY43-9006 - Phase II in Advanced Breast Cancer [Phase 2]
Summary
Phase II clinical trial of BAY43-9006 (sorafenib) in advanced breast cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Breast Neoplasms, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-06-23